SBI Securities’s Aura Biosciences AURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$214 Hold
34
– – ﹤0.01% 3390
2026
Q2
$241 Hold
34
– – ﹤0.01% 3270
2026
Q1
$227 Sell
34
-600
-95% -$3.44K ﹤0.01% 3175
2025
Q4
$3.46K Sell
634
-2
-0.3% -$12 ﹤0.01% 2176
2025
Q3
$3.93K Buy
636
+2
+0.3% +$13 ﹤0.01% 2144
2025
Q2
$3.97K Buy
634
+300
+90% +$1.76K ﹤0.01% 2098
2025
Q1
$1.96K Hold
334
– – ﹤0.01% 2301
2024
Q4
$2.74K Buy
+334
New +$3.14K ﹤0.01% 2174

Other funds holding AURA

SBI Securities's AURA Position: Q3 2026 in Review

SBI Securities held its Aura Biosciences (AURA) position steady in Q3 2026 at 34 shares worth $214. The position accounts for ﹤0.01% of the portfolio, ranked #3390.

SBI Securities first reported a position in AURA in Q4 2024 and has held it in 8 quarters since. The position peaked at $3.97K in Q2 2025. 98 funds tracked by Wall St. Rank hold AURA as of Q3 2026.

  • SBI Securities held 34 shares of Aura Biosciences worth $214 as of Q3 2026.
  • SBI Securities left its Aura Biosciences share count unchanged in Q3 2026.
  • Aura Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3390 holding.
  • SBI Securities first reported a position in Aura Biosciences in Q4 2024 and has held it in 8 quarters since.
  • SBI Securities's Aura Biosciences position peaked at $3.97K in Q2 2025.
  • 98 funds tracked by Wall St. Rank held Aura Biosciences as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.